FANGZHOU JIANKE News

Hong Kong Stock Afternoon Review | All three major indexes fell, the Hang Seng Index dropped below 22,000 points, falling over 1%; Network Technology stocks corrected, JD.com fell over 5%; Biotechnology stocks performed strongly against the trend, REMEGEN

Network Technology stocks fell, JD-SW dropped 5.29%, MEITUAN-W fell 4.85%; semiconductor stocks declined, HUA HONG SEMI dropped 3.72%, SOLOMON SYSTECH fell 2.44%; Digital Health stocks decreased, Dingdang Health dropped 2.99%, ALI HEALTH fell 2.74%.

Futu NewsApr 24 12:16

Hong Kong stocks are moving | Ark Jienke (06086) rose more than 11% at its peak as the company seizes the AI + Medical wave. Last year's adjusted Net income increased by 139% year-on-year.

Ark Health (06086) rose by more than 11% at its peak, and as of the time of writing, it is up 7.26%, trading at 4.43 Hong Kong dollars, with a transaction volume of 53.9317 million Hong Kong dollars.

Zhitong FinanceApr 24 10:41

FANGZHOU JIANKE: 2024 Annual Report

HKEXApr 23 16:56 · Announcements

Hong Kong Stock Afternoon Review | All three major Indexes fell, the technology index dropped over 4%; Network Technology stocks weakened, Meituan fell over 7%; some Golden Industrial Concept stocks rose against the trend, Chifeng Jilong Gold Mining incre

Network Technology stocks fell broadly, with MEITUAN-W down 7.43% and KUAISHOU-W down 6.25%; most Apple Supplier stocks also declined, COWELL down 6.83% and AAC TECH down 5.77%; Autos stocks fell broadly, with LEAPMOTOR down 7.87% and XPENG-W down 7.87%.

Futu NewsApr 16 12:13

Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models

PR NewswireApr 10 11:07

Fangzhou Widens Loss in 2024

MT NewswiresMar 24 17:22

Press Release: Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation

Dow JonesMar 24 11:01

Ark Health's stock price rose over 8%. The revenue for 2024 is 2.707 billion yuan, an increase of 11.2% year-on-year.

Ark Health (06086) saw its stock price rise by 8.67% after the earnings report, currently at HK$5.89, with a trading volume of HK$13.1188 million. On March 23, Ark Health (06086) released its performance announcement for the year ending December 31, 2024. In 2024, the company's revenue is expected to grow by 11.2% compared to 2023, reaching 2.707 billion yuan, mainly benefiting from increases in revenue from offline retail pharmacy services, wholesale, and customized content and marketing solutions.

Sina Hong Kong StocksMar 24 09:34

A forward-looking layout of "AI + Medical", adjusted Net income increased by 139% year-on-year. Technological innovation boosts Ark Health (06086) profit surge.

Amidst the waves of change, opportunities arise. Who is leading in AI + Digital Health? Companies that adhere to long-term development principles have provided the answer with impressive annual performance. On March 21, "the first stock of AI chronic disease management" Ark Health (06086) officially released its first annual report since going public.

Zhitong FinanceMar 22 00:07

Ark Health (06086.HK) achieved revenue of over 2.7 billion yuan for the fiscal year 2024, with adjusted net profit significantly increasing by 139%.

On March 21, the company announced its annual performance, reporting revenue of 2.707 billion yuan for the year ending December 31, 2024, an increase of 11.22% year-on-year; the adjusted net profit for 2024 is expected to grow significantly by 139% compared to 2023, benefiting from continuous technological enhancements and improved Operation efficiency. During the reporting period, the platform experienced strong growth, with increased user engagement. As of December 31, 2024, the platform's registered users rose to 49.2 million. For the twelve months ending December 31, 2024, the average monthly active users reached.

Gelonghui FinanceMar 21 23:12

FANGZHOU JIANKE: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024

HKEXMar 21 22:58 · Announcements

Hong Kong stocks movement | Ark Health (06086) rose over 17% during the session. DeepSeek accelerates the implementation of AI Medical, and the company will focus on developing multiple "Asia Vets smart assistant" scenarios this year.

Arc Health (06086) rose over 17% during the session, and as of this writing, is up 13.36%, priced at 5.77 Hong Kong dollars, with a transaction volume of 0.138 billion Hong Kong dollars.

Zhitong FinanceMar 21 11:14

Hong Kong stocks movement | Ark Health (06086) rose over 6% against the trend as the company recently entered the Hong Kong Stock Connect list and accessed DS to provide personalized medical services.

Ark Health (06086) rose over 6% against the market trend. As of the time of writing, it has increased by 2.71%, priced at 4.92 Hong Kong dollars, with a transaction volume of 25.8659 million Hong Kong dollars.

Zhitong FinanceMar 20 10:18

Ark Health (06086.HK) plans to hold a Board of Directors meeting on March 21 to approve the annual performance.

On March 11, Glonghui reported that Ark Health (06086.HK) announced that the company will hold a Board of Directors meeting on March 21, 2025 (Friday) to consider and approve the performance and its publication of the company and its subsidiaries for the financial year ending December 31, 2024, as well as to consider the distribution of final dividends (if any), and to address Other matters.

Gelonghui FinanceMar 11 16:52

FANGZHOU JIANKE: DATE OF BOARD MEETING

HKEXMar 11 16:46 · Announcements

Huawei has entered the AI Medical field! Ark Health has surged nearly 50%, leading the way, and Institutions believe commercialization is expected to accelerate.

① Can companies like Fangzhou Jianke and Yidu Technology truly solve the problem of medical resource shortages through localized deployment of large models in Hospital scenarios? ② Tianfeng proposes that the core contradiction in AI Medical shifts to "data value reassessment"; how will the high-barrier data of the Medical Industry and multimodal fusion technology become the key to corporate competition?

cls.cnMar 10 10:12

The adjustment of the Hong Kong Stock Connect securities list has taken effect, with multiple stocks rising in price due to their inclusion.

Jingu Financial News | The Shanghai Stock Exchange and the Shenzhen Stock Exchange have respectively released announcements stating that due to the periodic adjustment of constituent stocks in the Hang Seng Composite LargeCap Index, MidCap Index, and SmallCap Index, adjustments will be made to the list of securities included and excluded from the Stock Connect trading scope. These adjustments will officially take effect on March 10. Among the stocks included in the Stock Connect list this time, several individual stock prices have risen to varying degrees. Ark Health (06086) currently has a stock price increase of 50%; Mao Ge Ping (01318) has risen by 11.1%; CHINA TRAVEL HK (00308) has increased by 7.5%; Lionheng Holdings (02562) is up.

Jinwu Financial NewsMar 10 10:04

Hong Kong stocks movement丨Ark Health surged over 70%, included in the Hong Kong Stock Connect effective today.

On March 10th, Glonghui reported that Ark Health (6086.HK) surged in early trading, at one point soaring over 70% to 7.55 Hong Kong dollars, reaching a new high since December 20, 2024. In terms of news, both the Shanghai Stock Exchange and Shenzhen Stock Exchange issued announcements regarding the adjustments to the list of Hong Kong Stock Connect symbol securities, indicating that Ark Health has been included in the Stock Connect, effective from March 10, 2025. Market participants noted that after being included in the Stock Connect, Ark Health is expected to attract more mainland investors, which may increase liquidity and valuation levels.

Gelonghui FinanceMar 10 09:54

Express News | Hong Kong stocks of AI Medical Concept stocks are strong, with Ark Health rising nearly 50%.

BreakingsMar 10 09:47

Hong Kong Stock Announcement | FE HORIZON's net profit attributable to ordinary shareholders in 2024 is 3.862 billion yuan, a decrease of 37.63% year-on-year.

Chifeng Jilong Gold Mining (06693) was listed on March 10, with both the Hong Kong public offering and the international offering receiving slight oversubscription.

Zhitong FinanceMar 9 20:01